Oral branched-chain amino acids administration improves impaired liver dysfunction after radiofrequency ablation therapy for hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 56, Issue 94-95, 2009, Pages 1491-1495

  Ishikawa, Toru ^a   Michitaka, Imai ^a   Kamimura, Hiroteru ^a   Higuchi, Kazuo ^a   Kubota, Tomoyuki ^a   Seki, Kei Ichi ^a   Ohta, Hironobu ^a   Yoshida, Toshiaki ^a   Kamimura, Tomoteru ^a  

^a Saiseikai Niigata Second Hospital   (Japan)

Author keywords

Branched chain amino acid (BCAA) enriched nutrient mixture (BCAA mixture); Child pugh; Intrahepatic distant recurrence; Radiofrequency ablation (RFA)

Indexed keywords

AMINOLEBAN EN; BRANCHED CHAIN AMINO ACID; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; AMINO ACIDS, BRANCHED-CHAIN; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 71949105327     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Okuda K: Hepatocellular carcinoma J Hepatol. 2000; 32:.225-237.
2. Shiratori Y, Yoshida H, Omata M: Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention. Expert Rev Anticancer Ther 2001; 1:277-290. (Pubitemid 34679418)
3. Alsowmely AM, Hodgson HJ: Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2002; 16: 1-15.
4. Livraghi T: Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003; 10: 67-76. (Pubitemid 36850306)
5. Llovet JM, Real MI, Montana X, Planas R, Coli S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J, Bruix J: Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739.
6. Catalano O, Lobianco R, Esposito M, Siani A: Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns. Abdom Imaging. 2001; 26:375-383. (Pubitemid 32565867)
7. Cox DR: Regression models and life tables. J R Stat Soc 1972; 34: 248-275.
8. Ishikawa T, Ichida T, Yamagiwa S, Sugahara S, Uehara K, Okoshi S, Asakura H: High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis. J Gastroenterol Hepatol. 2001; 16:1274-1281. (Pubitemid 34088276)
9. Sato Y, Fujiwara K, Ogata I, Ohta Y, Hayashi S, Oka Y, Furui S, Oka H: Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments. Cancer. 1985; 55:2822-2825.
10. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS: Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210:655-661. (Pubitemid 29124024)
11. Ebara M, Ohto M, Sugiura N, Kita K, Yoshikawa M, Okuda K, Kondo F, Kondo Y: Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol. 1990; 5:616-626.
12. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-240. (Pubitemid 36736097)
13. Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H: Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol. 2001; 31:322-326. (Pubitemid 32791460)
14. Hutson SM, Harris RA: Introduction. Symposium: Leucine as a nutritional signal. J Nutr. 2001; 131:839S-840S.
15. Tomiya T, Inoue Y, Yanase M, Arai M, Ikeda H, Tejima K, Nagashima K, Nishikawa T, Fujiwara K: Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun. 2002; 297:1108-1111.
16. Owen OE, Mozzoli MA, Reichle FA, Kreulen TH, Owen RS, Boden G, Polansky M: Hepatic and renal metabolism before and after portasystemic shunts in patients with cirrhosis. J Clin Invest. 1985; 76:1209-1217.
17. Chang WK, Chao YC, Tang HS, Lang HF, Hsu CT: Effects of extra-carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. J Parenter Enteral Nutr. 1997;21:96-99.
18. Okamoto M, Sakaida I, Tsuchiya M, Suzuki C, Okita K: Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. Hepatol Res. 2003 ;27:45-50. (Pubitemid 37168651)
19. Sakaida I, Tsuchiya M, Okamoto M, Okita K: Late evening snack and the change of blood glucose level in patients with liver cirrhosis. Hepatol Res. 2004; 30S:67-72.
20. Tsuchiya M, Sakaida I, Okamoto M, Okita K: The effect of a late evening snack in patients with liver cirrhosis. Hepatol Res. 2005 ;31:95-103. (Pubitemid 40378714)
21. Aoyama K, Tsuchiya M, Mori K, Kubo Y, Shiraishi K, Sakaguchi E, Yamashita S, Sakaida I: Effect of a late evening snack on outpatients with liver cirrhosis. Hepatol Res. 2007; 37:608-614. (Pubitemid 47009246)
22. Okuda H, Shiratori K: Long-term nutritional assessment and quality of life in patients with cirrhosis taking a late evening snack. J Gastroenterol. 2007; 42:186-187. (Pubitemid 46404225)
23. Ohfuji S, Fukushima W, Tanaka T, Habu D, Takeda T, Tamori A, Sakaguchi H, Seki S, Kawada N, Nishiguchi S, Shiomi S, Hirota Y: Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C? Hepatol Res. 2008; 38: 860-868.
24. Habu D, Nishiguchi S, Nakatani S, Kawamura E, Lee C, Enomoto M, Tamori A, Takeda T, Tanaka T, Shiomi S: Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial. Hepatol Res. 2003; 25:312-318. (Pubitemid 36546358)
25. Nakaya Y, Harada N, Kakui S, Okada K, Takahashi A, Inoi J, Ito S: Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture. J Gastroenterol. 2002;37:531-536. (Pubitemid 34893330)
26. Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, Shiraishi K, Okuda H, Onji M, Kanazawa H, Tsubouchi H, Kato S, Kaito M, Watanabe A, Habu D, Ito S, Ishikawa T, Kawa.mura N, Arakawa Y: Hepatic Nutritional Therapy (HNT) Study Group. BCAA-enriched snack improves nutritional state of cirrhosis Nutrition. 2007 ;23:113-120.